Literature DB >> 3616783

Alterations of bone and mineral metabolism in diabetes mellitus. Part II. Clinical studies in 206 patients with type I diabetes mellitus.

F S Hough.   

Abstract

This study reports a 22% prevalence of significant cortical osteopenia in 206 patients, aged 7-20 years, with established insulin-dependent diabetes mellitus (IDDM). A parallel decrease in trabecular bone mass was also noted. Bone loss was more evident in males (16%) than in females (6%) and was rare before 10 years of age (3%). No relationship between bone loss and the duration of diabetes, degree of metabolic control or diabetic complications was apparent. Delayed skeletal maturation did not account for cortical thinning, and the mean bone age of osteopenic diabetics was similar to that of non-osteopenic diabetics. There was no significant correlation between HLA-antigen frequency and the predisposition to diabetic osteopenia. Metabolic alterations comparable with previous findings in the chronically diabetic rat were documented in IDDM. The data documented are consistent with the conclusion that IDDM results in intestinal hyperabsorption of calcium, absorptive hypercalciuria, phosphaturia, hypomagnesaemia, hyperphosphatasaemia, and decreased circulating parathyroid hormone levels. These alterations in mineral metabolism may relate to the decrease in cortical and trabecular bone mass observed in patients with IDDM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3616783

Source DB:  PubMed          Journal:  S Afr Med J


  10 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

Review 2.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

3.  Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria.

Authors:  A Verrotti; F Basciani; F Carle; G Morgese; F Chiarelli
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Evaluation of bone mineral density in children with diabetes mellitus.

Authors:  B Ersoy; D Gökşen; S Darcan; E Mavi; C Oztürk
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

5.  Treatment of osteopenia in children with insulin-dependent diabetes mellitus: the effect of 1 alpha-hydroxyvitamin D3.

Authors:  A Al-Qadreh; I Voskaki; C Kassiou; H Athanasopoulou; E Sarafidou; C S Bartsocas
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

6.  Osteocalcin levels in diabetic subjects.

Authors:  M Pedrazzoni; G Ciotti; G Pioli; G Girasole; L Davoli; E Palummeri; M Passeri
Journal:  Calcif Tissue Int       Date:  1989-12       Impact factor: 4.333

7.  Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population.

Authors:  Song-Seng Loke; Hsueh-Wen Chang; Wen-Cheng Li
Journal:  J Bone Miner Metab       Date:  2017-03-16       Impact factor: 2.626

8.  Islet transplantation reverses carcass protein loss in diabetic rats without inducing disproportionate fat accumulation.

Authors:  B W Tobin; M J Marchello
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

Review 9.  Regulation of serum phosphate.

Authors:  Eleanor Lederer
Journal:  J Physiol       Date:  2014-06-27       Impact factor: 5.182

10.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.